Showing results (2841-2850 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|February 16, 2010
The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UKAgnes Benedict, Lara Verdian, Grant Maclaine
Pharmacoeconomics|August 26, 2016
The Societal Cost of Schizophrenia: A Systematic ReviewHuajie Jin, Iris Mosweu
Pharmacoeconomics|September 2, 2016
Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic DiseasesPaul S J Miller, Harry Hill, Fredrik L Andersson
Pharmacoeconomics|May 29, 2017
Cost-Effectiveness of Drug Treatments for Advanced Melanoma: A Systematic Literature ReviewDarío Rubio-Rodríguez, Silvia De Diego Blanco, Maite Pérez, et al.
Pharmacoeconomics|June 21, 2017
Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information AnalysisEric Jutkowitz, Fernando Alarid-Escudero, Hyon K Choi, et al.
Pharmacoeconomics|March 13, 2010
A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatmentJean-Eric Tarride, Robert Hopkins, Gord Blackhouse, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Pharmacoeconomics|February 6, 2010
Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic reviewWilliam A Prescott, Fred Doloresco, Jack Brown, et al.
Pageof 336